Table 7. Number of somatic symptoms reported at follow-up according to number of somatic symptoms reported at baseline.
Number of symptoms at baseline | Number of symptoms at follow-up | |||||||
---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
0 | 3,329 | 622 | 235 | 107 | 49 | 18 | 10 | 7 |
1 | 885 | 479 | 216 | 108 | 47 | 15 | 2 | 0 |
2 | 452 | 293 | 217 | 101 | 52 | 21 | 12 | 2 |
3 | 230 | 151 | 137 | 98 | 54 | 16 | 14 | 4 |
4 | 141 | 71 | 81 | 75 | 47 | 29 | 19 | 5 |
5 | 51 | 31 | 40 | 41 | 26 | 17 | 7 | 5 |
6 | 20 | 12 | 18 | 16 | 13 | 16 | 9 | 5 |
7 | 19 | 13 | 5 | 10 | 5 | 11 | 8 | 7 |
Analysis was restricted to the 8,856 participants who provided complete information about somatic symptoms at both baseline and follow-up.